EP 3630729 B1 20211103 - PYRIMIDINE COMPOUND
Title (en)
PYRIMIDINE COMPOUND
Title (de)
PYRIMIDINVERBINDUNG
Title (fr)
COMPOSÉ DE PYRIMIDINE
Publication
Application
Priority
- JP 2017020322 W 20170531
- JP 2018020997 W 20180531
Abstract (en)
[origin: WO2018221667A1] The present invention provides a novel pyrimidine compound represented by Formula [I] and a salt thereof: [in the formula, the symbols are as defined in the specification], which is useful for treating, preventing and/or diagnosing seizure and the like in disease involving epileptic seizure or convulsive seizure (including multiple drug resistant seizure, refractory seizure, acute symptomatic seizure, febrile seizure and status epilepticus), as well as a medical use therefor.
IPC 8 full level
C07D 239/22 (2006.01); A61K 31/506 (2006.01); A61P 25/08 (2006.01); C07D 239/54 (2006.01)
CPC (source: EA EP IL KR US)
A61K 31/513 (2013.01 - IL KR); A61P 25/08 (2018.01 - EA EP KR US); C07D 239/22 (2013.01 - EA EP IL KR); C07D 239/54 (2013.01 - EA EP IL KR); C07D 401/14 (2013.01 - EA IL KR US); C07D 403/04 (2013.01 - EA IL KR US); C07F 7/0812 (2013.01 - EA IL KR US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2018221667 A1 20181206; AU 2018277949 A1 20191212; AU 2018277949 B2 20211118; BR 112019023988 A2 20200630; CA 3064176 A1 20181206; CN 110603248 A 20191220; CN 110603248 B 20230704; CY 1125073 T1 20230324; DK 3630729 T3 20211213; EA 038907 B1 20211108; EA 201992831 A1 20200330; EP 3630729 A1 20200408; EP 3630729 B1 20211103; ES 2901452 T3 20220322; HR P20211913 T1 20220304; HU E056942 T2 20220328; IL 270579 A 20191231; IL 270579 B1 20230401; IL 270579 B2 20230801; JP 2020503334 A 20200130; JP 6739653 B2 20200812; KR 20200011962 A 20200204; LT 3630729 T 20220110; MX 2019014384 A 20200123; PH 12019502639 A1 20200608; PL 3630729 T3 20220124; PT 3630729 T 20211216; SA 519410563 B1 20220725; SI 3630729 T1 20220131; TW 201902890 A 20190116; TW 202346283 A 20231201; TW I808974 B 20230721; US 10800758 B2 20201013; US 2020017476 A1 20200116; US 2020399245 A1 20201224; US 2023138411 A1 20230504; WO 2018220762 A1 20181206
DOCDB simple family (application)
JP 2018020997 W 20180531; AU 2018277949 A 20180531; BR 112019023988 A 20180531; CA 3064176 A 20180531; CN 201880030366 A 20180531; CY 211101091 T 20211213; DK 18732930 T 20180531; EA 201992831 A 20180531; EP 18732930 A 20180531; ES 18732930 T 20180531; HR P20211913 T 20180531; HU E18732930 A 20180531; IL 27057919 A 20191112; JP 2017020322 W 20170531; JP 2019535398 A 20180531; KR 20197037748 A 20180531; LT 18732930 T 20180531; MX 2019014384 A 20180531; PH 12019502639 A 20191122; PL 18732930 T 20180531; PT 18732930 T 20180531; SA 519410563 A 20191114; SI 201830499 T 20180531; TW 107118471 A 20180530; TW 112129778 A 20180530; US 201816471998 A 20180531; US 202017010182 A 20200902; US 202218091790 A 20221230